Intracerebroventricular administration of neuronostatin induces depression-like effect in forced swim test of mice

Peptides

Volumn 32, Issue 9, 2011, Pages 1948-1952

  Yang, Ai Min ^a   Ji, Yue Ke ^a   Su, Shu Fang ^a   Yang, Shao Bin ^a   Lu, Song Song ^a   Mi, Ze Yun ^a   Yang, Qing Zhen ^a   Chen, Qiang ^a  

^a LANZHOU UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; AMINO ACID DERIVATIVE; BICUCULLINE; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NALOXONE; NEURONOSTATIN; PEPTIDE HORMONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; FORCED SWIMMING TEST; LOCOMOTION; MALE; MOOD; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AFFECT; ANIMALS; BICUCULLINE; DEPRESSION; GABA-A RECEPTOR ANTAGONISTS; INFUSIONS, INTRAVENTRICULAR; MALE; MELANOCYTE-STIMULATING HORMONES; MICE; MOTOR ACTIVITY; NALOXONE; PEPTIDE HORMONES; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTORS, GABA-A; RECEPTORS, OPIOID; SOLID-PHASE SYNTHESIS TECHNIQUES; SWIMMING; TIME FACTORS;

MUS;

EID: 80052708188     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2011.08.012     Document Type: Article

References (34)

1. K.O. Aley, and S.K. Kulkarni GABA-mediated modification of despair behavior in mice Naunyn Schmiedebergs Arch Pharmacol 339 1989 306 311 (Pubitemid 19094817)
2. H. Anisman, Z. Merali, and S. Hayley Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders Prog Neurobiol 85 2008 1 74
3. M. Ari, O.H. Ozturk, Y. Bez, S. Oktar, and D. Erduran High plasma nesfatin-1 level in patients with major depressive disorder Prog Neuropsychopharmacol Biol Psychiatry 35 2011 497 500
4. A. Bertolini, R. Tacchi, and A.V. Vergoni Brain effects of melanocortins Pharmacol Res 59 2009 13 47
5. P. Brambilla, J. Perez, F. Barale, G. Schettini, and J.C. Soares GABAergic dysfunction in mood disorders Mol Psychiatry 8 2003 721 737 (Pubitemid 36976430)
6. S. Chaki, and T. Okubo Melanocortin-4 receptor antagonists for the treatment of depression and anxiety disorders Curr Top Med Chem 7 2007 1145 1151 (Pubitemid 47040517)
7. S. Chaki, and S. Okuyama Involvement of melanocortin-4 receptor in anxiety and depression Peptides 26 2005 1952 1964 (Pubitemid 41354554)
8. R.D. Cone Anatomy and regulation of the central melanocortin system Nat Neurosci 8 2005 571 578 (Pubitemid 40594196)
9. R.D. Cone Studies on the physiological functions of the melanocortin system Endocr Rev 27 2006 736 749 (Pubitemid 44936057)
10. L.N. Davies, J.S. Wolffsohn, and B. Gilmartin Autonomic correlates of ocular accommodation and cardiovascular function Ophthalmic Physiol Opt 29 2009 427 435
11. S.L. Dun, G.C. Brailoiu, A.A. Tica, J. Yang, J.K. Chang, and E. Brailoiu Neuronostatin is co-expressed with somatostatin and mobilizes calcium in cultured rat hypothalamic neurons Neuroscience 166 2010 455 463
12. E. Engin, J. Stellbrink, D. Treit, and C.T. Dickson Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: behavioral and neurophysiological evidence Neuroscience 157 2008 666 676
13. E. Engin, and D. Treit Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors Psychopharmacology (Berl) 206 2009 281 289
14. R. Genud, A. Merenlender, I. Gispan-Herman, R. Maayan, A. Weizman, and G. Yadid DHEA lessens depressive-like behavior via GABA-ergic modulation of the mesolimbic system Neuropsychopharmacology 34 2009 577 584
15. T.J. Haley, and W.G. McCormick Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse Br J Pharmacol Chemother 12 1957 12 15
16. C. Hill, and J.C. Dunbar The effects of acute and chronic alpha melanocyte stimulating hormone (alphaMSH) on cardiovascular dynamics in conscious rats Peptides 23 2002 1625 1630 (Pubitemid 35246282)
17. Y. Hua, H. Ma, W.K. Samson, and J. Ren Neuronostatin inhibits cardiac contractile function via a protein kinase A- and JNK-dependent mechanism in murine hearts Am J Physiol Regul Integr Comp Physiol 297 2009 R682 R689
18. A.V. Kalueff, and D.J. Nutt Role of GABA in anxiety and depression Depress Anxiety 24 2007 495 517 (Pubitemid 350086263)
19. G.F. Koob, and S.C. Heinrichs A role for corticotropin releasing factor and urocortin in behavioral responses to stressors Brain Res 848 1999 141 152 (Pubitemid 30001663)
20. G.X. Liu, G.Q. Cai, Y.Q. Cai, Z.J. Sheng, J. Jiang, and Z. Mei Reduced anxiety and depression-like behaviors in mice lacking GABA transporter subtype 1 Neuropsychopharmacology 32 2007 1531 1539 (Pubitemid 46920158)
21. J. Liu, J.C. Garza, H.V. Truong, J. Henschel, W. Zhang, and X.Y. Lu The melanocortinergic pathway is rapidly recruited by emotional stress and contributes to stress-induced anorexia and anxiety-like behavior Endocrinology 148 2007 5531 5540 (Pubitemid 350012649)
22. N. Matussek Opioid system in depression Int J Neuropsychopharmacol 6 2003 443 (Pubitemid 38146265)
23. Z. Merali, C. Cayer, P. Kent, and H. Anisman Nesfatin-1 increases anxiety- and fear-related behaviors in the rat Psychopharmacology (Berl) 201 2008 115 123
24. E.J. Nestler, M. Barrot, R.J. DiLeone, A.J. Eisch, S.J. Gold, and L.M. Monteggia Neurobiology of depression Neuron 34 2002 13 25 (Pubitemid 34270695)
25. M.L. Phillips, W.C. Drevets, S.L. Rauch, and R. Lane Neurobiology of emotion perception I: the neural basis of normal emotion perception Biol Psychiatry 54 2003 504 514 (Pubitemid 37289437)
26. R.D. Porsolt, A. Bertin, and M. Jalfre Behavioral despair in mice: a primary screening test for antidepressants Arch Int Pharmacodyn Ther 229 1977 327 336 (Pubitemid 8225714)
27. T.L. Rao, D.M. Kokare, S. Sarkar, R.T. Khisti, C.T. Chopde, and N. Subhedar GABAergic agents prevent alpha-melanocyte stimulating hormone induced anxiety and anorexia in rats Pharmacol Biochem Behav 76 2003 417 423 (Pubitemid 37487897)
28. W.K. Samson, J.V. Zhang, O. Avsian-Kretchmer, K. Cui, G.L. Yosten, and C. Klein Neuronostatin encoded by the somatostatin gene regulates neuronal, cardiovascular, and metabolic functions J Biol Chem 283 2008 31949 31959
29. P.P. Silveira, M.H. Xavier, F.H. Souza, L.P. Manoli, R.M. Rosat, and M.B. Ferreira Interaction between repeated restraint stress and concomitant midazolam administration on sweet food ingestion in rats Braz J Med Biol Res 33 2000 1343 1350
30. R.P. Vertes Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat Neuroscience 142 2006 1 20 (Pubitemid 44353937)
31. A.M. Yang, W.W. Ge, S.S. Lu, S.B. Yang, S.F. Su, and Z.Y. Mi Central administration of neuronostatin induces antinociception in mice Peptides 32 2011 1893 1901
32. Q.Z. Yang, S.S. Lu, X.Z. Tian, A.M. Yang, W.W. Ge, and Q. Chen The antidepressant-like effect of human opiorphin via opioid-dependent pathways in mice Neurosci Lett 489 2011 131 135
33. G.L. Yosten, A.T. Pate, and W.K. Samson Neuronostatin acts in brain to biphasically increase mean arterial pressure through sympatho-activation followed by vasopressin secretion: the role of melanocortin receptors Am J Physiol Regul Integr Comp Physiol 300 2011 R1194 R1199
34. G.L. Yosten, and W.K. Samson The melanocortins, not oxytocin, mediate the anorexigenic and antidipsogenic effects of neuronostatin Peptides 31 2010 1711 1714